Nobipharm sp. z o.o.

Other professional, scientific and technical activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-04-23
Share capital
50,000.00 PLN
Activity description

Nobipharm is a pharmaceutical wholesaler that offers medicinal products in therapeutic areas such as immunoglobulins, albumins, intensive therapy, and hemophilia. The company also provides medical devices and diagnostic equipment.

Registered address
Rydygiera 8, 01-793 Warszawa, Poland
Opening hours
Mon–Fri, 8:30–15:30
Email
Electronic delivery address
AE:PL-77499-24171-JSSGC-15

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 audited by a statutory auditor.

  • 2025not filed
  • 202426/06/2025
  • 202326/06/2024
  • 202228/06/2023
  • 202122/04/2022
  • 202017/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Voivodeship · Mazowieckie7,750 / 142,215
Top 5.5%
Country · Poland26,391 / 496,512
Top 5.3%

Results vs industry

Revenue
This companyUSD 9.45mMedianUSD 70.87kAverageUSD 515.82k
Net profit
This companyUSD 1.36mMedianUSD 2.57kAverageUSD 5.50k
Operating costs
This companyUSD 7.65mMedianUSD 57.18kAverageUSD 446.37k
Assets
This companyUSD 5.12mMedianUSD 61.04kAverageUSD 1.39m

Offer

Certifications: ISO 9001

Websites

The site is available in: Polish and English.

  • nobipharm.plStrona główna – Nobipharm
    WordPress 6.9ElementorPolylangNginx

Public procurement

378 tenders recorded as contractor: 86 national ($2,696,347) and 292 EU ($27,904,539).

SubjectAmount
Supply of medicines, lots 1–41
–
Supply of medicines and compounding accessories
$12,858
Successive supply of medicines to the hospital pharmacy
$35,927

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2000.

MarkNumberClassesStatusProtected until
NOBIPHARM (word)Z.3934351, 3, 5, 10, 35, 39, 44Protected Nov 29, 2031
NOBIPHARM Z.2230665, 10Expired –
MarkProtected until
NOBIPHARM (word)Nov 29, 2031
NOBIPHARM –

Authorized Representatives

Tomasz Jerzy Nowak age 76 – General Director

Manner of representation

The President of the Management Board – General Director – independently; in the event of the appointment of a multi-member management board, the President of the Management Board – General Director – independently, two members of the management board jointly, a member of the management board jointly with a commercial proxy, or two commercial proxies jointly.

Ownership

OwnerSharesShare valueStake
330$4,457.0533%
670$9,049.1667%

Tomasz Jerzy Nowak and Krzysztof Nowak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1996-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

10 public aid cases recorded, with a total value of $400,785.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$17,288
De minimis aid (in accordance with Commission Regulation 2023/2831)
$32,145
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$12,027

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Medyk-Lek Panek sp. z o.o. sp. k.
Qpharma sp. z o.o.
Biomedica Poland sp. z o.o.
Allpharm sp. z o.o. sp. k.
Orion Pharma Poland sp. z o.o.
Interpharma sp. z o.o.
Medinn sp. z o.o.
Trumedico Pl sp. z o.o. + limited partnership
Bialmed Logistyka sp. z o.o. + limited partnership
Bionesis sp. z o.o.

Change history

DateEvent
2006-01-19Share capital increase
2003-03-03Share capital increase
2002-04-23Entered in the register

FAQ

Last updated: 2026-04-04